Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cyclo Therapeutics Inc (CYTH)

Cyclo Therapeutics Inc (CYTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,844
  • Shares Outstanding, K 6,438
  • Annual Sales, $ 900 K
  • Annual Income, $ -8,940 K
  • 60-Month Beta -0.99
  • Price/Sales 47.13
  • Price/Cash Flow N/A
  • Price/Book 4.17
Trade CYTH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.07 +12.15%
on 09/14/21
7.90 -13.80%
on 08/31/21
-0.64 (-8.59%)
since 08/17/21
3-Month
6.07 +12.15%
on 09/14/21
11.49 -40.73%
on 06/18/21
-3.75 (-35.51%)
since 06/17/21

Most Recent Stories

More News
Thinking about buying stock in AMC Entertainment, AnPac Bio-Medical Science, General Electric, JPMorgan, or Cyclo Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, ANPC, GE, JPM, and CYTH.

AC : 35.12 (-2.01%)
ANPC : 3.58 (+4.99%)
CYTH : 6.81 (+3.03%)
AMC : 44.20 (-4.00%)
GE : 100.47 (-0.86%)
JMP : 7.48 (unch)
GEC.LN : 101.380 (unch)
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FSR, TRCH, NTEC, SUPN, and CYTH.

CYTH : 6.81 (+3.03%)
SUPN : 27.28 (+0.33%)
NTEC : 9.63 (-12.48%)
TRCH : 4.95 (+4.21%)
FSR : 13.50 (+7.06%)
Thinking about buying stock in Eloxx Pharmaceuticals, Sio Gene Therapies, Ampio Pharmaceuticals, Applied Genetic Technologies, or Cyclo Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ELOX, SIOX, AMPE, AGTC, and CYTH.

AMPE : 1.8000 (+5.88%)
AGTC : 3.43 (+2.69%)
CYTH : 6.81 (+3.03%)
ELOX : 1.8700 (+6.86%)
SIOX : 2.22 (-0.89%)
Thinking about buying stock in Virgin Galactic, Cyclo Therapeutics, Beyond Meat, Eloxx Pharmaceuticals, or Reata Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SPCE, CYTH, BYND, ELOX, and RETA.

BYND : 112.95 (+4.34%)
CYTH : 6.81 (+3.03%)
ELOX : 1.8700 (+6.86%)
RETA : 109.94 (+2.20%)
SPCE : 26.42 (+7.88%)
Cyclo Therapeutics Appoints Russ Belden as Acting Chief Commercial Officer

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for...

DNA : 12.18 (+9.24%)
CYTH : 6.81 (+3.03%)
Thinking about buying stock in Anavex Life Sciences, Lizhi, vTv Therapeutics, Atossa Therapeutics, or Cyclo Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVXL, LIZI, VTVT, ATOS, and CYTH.

CYTH : 6.81 (+3.03%)
LIZI : 3.71 (-1.33%)
VTVT : 1.7800 (+2.89%)
ATOS : 3.58 (+4.99%)
AVXL : 17.63 (+3.89%)

Business Summary

Cyclo Therapeutics Inc. is a clinical-stage biotechnology company. It develops cyclodextrin-based products for the treatment of disease. The company's Trappsol(R) Cyclo(TM), an orphan drug designated product primarily in the United States and Europe, is in ongoing formal clinical trials for Niemann-Pick...

See More

Key Turning Points

3rd Resistance Point 7.23
2nd Resistance Point 7.03
1st Resistance Point 6.92
Last Price 6.81
1st Support Level 6.61
2nd Support Level 6.40
3rd Support Level 6.29

See More

52-Week High 17.75
Fibonacci 61.8% 12.33
Fibonacci 50% 10.65
Fibonacci 38.2% 8.97
Last Price 6.81
52-Week Low 3.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar